PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
Authors
Keywords
PSCA, ERG, Tissue microarray, Prostate cancer, Immunohistochemistry
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-31
DOI
10.1186/s12885-018-4547-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apurinic/apyrimidinic endonuclease 1 (APE1/Ref-1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion
- (2017) Manuela Juhnke et al. MOLECULAR CARCINOGENESIS
- PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma
- (2016) Li-Yi Zhang et al. CARCINOGENESIS
- Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer
- (2016) Waldemar Wilczak et al. CARCINOGENESIS
- Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
- (2016) Guido Sauter et al. EUROPEAN UROLOGY
- p16 upregulation is linked to poor prognosis in ERG negative prostate cancer
- (2016) Christoph Burdelski et al. TUMOR BIOLOGY
- Biomarkers for Evaluation of Prostate Cancer Prognosis
- (2015) Maryam Esfahani et al. Asian Pacific Journal of Cancer Prevention
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Down-regulation of prostate stem cell antigen (PSCA) by Slug promotes metastasis in nasopharyngeal carcinoma
- (2015) Li Wang et al. JOURNAL OF PATHOLOGY
- High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer
- (2015) Nathaniel Melling et al. PLoS One
- Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer
- (2015) Nathaniel Melling et al. PROSTATE
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- Expression of prostate stem cell antigen (PSCA) in prostate cancer: A tissue microarray study of Iranian patients
- (2013) Jaleh Taeb et al. PATHOLOGY RESEARCH AND PRACTICE
- Detection of Prostate Stem Cell Antigen Expression in Human Prostate Cancer Using Quantum-Dot-Based Technology
- (2012) Yuan Ruan et al. SENSORS
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- Identification of markers of prostate cancer progression using candidate gene expression
- (2011) S E T Larkin et al. BRITISH JOURNAL OF CANCER
- Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers
- (2011) Xiaohu Gu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis
- (2011) Hiroe Ono et al. GENES CHROMOSOMES & CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2010) S. Gupta et al. CANCER RESEARCH
- Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer
- (2010) S. Minner et al. CLINICAL CANCER RESEARCH
- Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?
- (2010) N. Saeki et al. CLINICAL CANCER RESEARCH
- Clinical Significance of Prostate Stem Cell Antigen Expression in Non-small Cell Lung Cancer
- (2010) Takeshi Kawaguchi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Integration ofERGgene mapping and gene-expression profiling identifies distinct categories of human prostate cancer
- (2008) Sameer Jhavar et al. BJU INTERNATIONAL
- Prostate stem cell antigen: A prospective therapeutic and diagnostic target
- (2008) Adam B. Raff et al. CANCER LETTERS
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer
- (2008) Hiromi Sakamoto et al. NATURE GENETICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now